• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾母细胞瘤病例的组织病理学特征及增殖标志物研究

Study of histopathological features and proliferation markers in cases of Wilms' tumor.

作者信息

Das Ram Narayan, Chatterjee Uttara, Sinha Swapan K, Ray Ashoke K, Saha Koushik, Banerjee Sugato

机构信息

Department of Pathology, I.P.G.M.E and R, Kolkata, West Bengal, India.

出版信息

Indian J Med Paediatr Oncol. 2012 Apr;33(2):102-6. doi: 10.4103/0971-5851.99744.

DOI:10.4103/0971-5851.99744
PMID:22988352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3439786/
Abstract

CONTEXT

The spectrum of pediatric renal tumors is different from adult renal tumors, and Wilms' tumor (WT) forms the majority. The histological type and clinicopathological staging are the two important prognostic parameters. The role of newer prognostic factors is not clear.

AIMS

This study was performed to analyze the histopathological spectrum of pediatric renal tumors and to study the expression of proliferation markers (Ki-67 and p53) in WT and correlate its expression in epithelial and blastema components in different stages.

MATERIALS AND METHODS

Twenty-seven cases of pediatric renal tumors were collected over 2 years. Hematoxylin-eosin staining was used for diagnosis. Immunostaining was performed for Ki-67 and p53. Ki-67 proliferation index (PI) and p53 expression were determined in each case and for the epithelial and blastema components separately.

STATISTICAL ANALYSIS AND RESULTS

We had 20 cases of WT (74.1%), three cases of mesoblastic nephroma (11.1%), three cases of clear cell sarcoma (11.1%) and one case of rhabdoid tumor (3.7%). It was observed that the PI of the epithelial component (57.2%) was significantly higher than that of blastema (39.53%) in all stages. The PI in Stage II is significantly higher than that in Stage I. Statistical analysis could not be performed in Stages III and IV due to the small number of cases. p53 expression did not show any significant difference in the epithelial and blastema components. There was also no significant difference between the stages.

CONCLUSION

In this study, we found the differences between PI of different tissue components of WT, with the epithelial component having a higher PI, which correlated with the stage of advancement of the disease.

摘要

背景

小儿肾肿瘤的谱系与成人肾肿瘤不同,其中肾母细胞瘤(WT)占大多数。组织学类型和临床病理分期是两个重要的预后参数。新的预后因素的作用尚不清楚。

目的

本研究旨在分析小儿肾肿瘤的组织病理学谱系,并研究增殖标志物(Ki-67和p53)在WT中的表达,并将其在不同阶段的上皮和胚芽成分中的表达进行关联。

材料和方法

在2年时间内收集了27例小儿肾肿瘤病例。采用苏木精-伊红染色进行诊断。对Ki-67和p53进行免疫染色。分别测定每例以及上皮和胚芽成分的Ki-67增殖指数(PI)和p53表达。

统计分析与结果

我们有20例WT(74.1%),3例中胚层肾瘤(11.1%),3例透明细胞肉瘤(11.1%)和1例横纹肌样瘤(3.7%)。观察到在所有阶段上皮成分的PI(57.2%)显著高于胚芽成分(39.53%)。II期的PI显著高于I期。由于病例数少,无法对III期和IV期进行统计分析。p53表达在上皮和胚芽成分中未显示任何显著差异。各阶段之间也无显著差异。

结论

在本研究中,我们发现WT不同组织成分的PI之间存在差异,上皮成分的PI较高,这与疾病的进展阶段相关。

相似文献

1
Study of histopathological features and proliferation markers in cases of Wilms' tumor.肾母细胞瘤病例的组织病理学特征及增殖标志物研究
Indian J Med Paediatr Oncol. 2012 Apr;33(2):102-6. doi: 10.4103/0971-5851.99744.
2
Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.肾母细胞瘤中核紊乱及p53免疫染色的评估
J Egypt Natl Canc Inst. 2011 Mar;23(1):31-9. doi: 10.1016/j.jnci.2011.07.005. Epub 2011 Sep 8.
3
Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.使用增殖细胞核抗原和MIB-1(Ki-67等效抗原)免疫染色分析肾母细胞瘤成分的相对增殖率并评估有丝分裂指数。
Lab Invest. 1994 Jan;70(1):125-9.
4
Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.成人肾母细胞瘤中的7号染色体长臂等臂染色体:诊断及发病机制意义
Am J Surg Pathol. 2000 Dec;24(12):1663-9. doi: 10.1097/00000478-200012000-00011.
5
Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.肾母细胞瘤-1蛋白(WT-1)免疫染色在小儿肾肿瘤中的诊断效用
Indian J Med Res. 2016 May;143(Supplement):S59-S67. doi: 10.4103/0971-5916.191776.
6
p53 expression in Wilms' tumor: a possible role as prognostic factor.p53在肾母细胞瘤中的表达:作为预后因素的可能作用。
Int J Oncol. 2001 Jan;18(1):133-9.
7
Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.耐药标志物DNA拓扑异构酶IIα和谷胱甘肽S-转移酶π在肾母细胞瘤组织学分区中的差异表达。
Anticancer Res. 2001 Jan-Feb;21(1B):771-6.
8
[New aspects of nephroblastoma (Wilms tumor) and other metanephrogenic neoplasms].肾母细胞瘤(威尔姆斯瘤)及其他后肾源性肿瘤的新进展
Verh Dtsch Ges Pathol. 1989;73:350-71.
9
MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.肾母细胞瘤中MIB-1(KI-67)增殖指数及细胞周期蛋白依赖性激酶抑制剂p27(Kip1)蛋白表达
Clin Cancer Res. 2004 Jan 15;10(2):591-7. doi: 10.1158/1078-0432.ccr-0884-02.
10
Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.原癌基因Bcl-X(S/L)在肾母细胞瘤中的表达意义
Ren Fail. 2005;27(1):13-8.

引用本文的文献

1
High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda.乌干达西南部肾母细胞瘤患儿存档组织块中WT1高表达及p53低表达
Cancer Manag Res. 2024 Mar 6;16:127-136. doi: 10.2147/CMAR.S449982. eCollection 2024.
2
Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis.肾母细胞瘤中 P53 蛋白的免疫组织化学表达:不良预后的预测指标。
J Egypt Natl Canc Inst. 2023 Jul 31;35(1):23. doi: 10.1186/s43046-023-00183-2.
3
Does immunohistochemical staining of P53, Ki 67 and cyclin A accurately predict Wilms tumor recurrence and survival?

本文引用的文献

1
MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.肾母细胞瘤中MIB-1(KI-67)增殖指数及细胞周期蛋白依赖性激酶抑制剂p27(Kip1)蛋白表达
Clin Cancer Res. 2004 Jan 15;10(2):591-7. doi: 10.1158/1078-0432.ccr-0884-02.
2
p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.组织学类型良好的肾母细胞瘤中p53的积累与血管生成及临床侵袭性疾病相关。
J Pediatr Surg. 2002 Mar;37(3):523-7. doi: 10.1053/jpsu.2002.30858.
3
Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
P53、Ki 67和细胞周期蛋白A的免疫组化染色能否准确预测肾母细胞瘤的复发和生存情况?
Arab J Urol. 2022 Apr 11;20(3):107-114. doi: 10.1080/2090598X.2022.2058240. eCollection 2022.
4
MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.miR-34a:肾细胞癌标志性特征的关键调节因子。
Oxid Med Cell Longev. 2017;2017:3269379. doi: 10.1155/2017/3269379. Epub 2017 Sep 20.
5
Immunohistochemical Expression of Ki67 and p53 in Wilms Tumor and Its Relationship with Tumor Histology and Stage at Presentation.Ki67和p53在肾母细胞瘤中的免疫组化表达及其与肿瘤组织学和初诊时分期的关系。
Patholog Res Int. 2016;2016:6123951. doi: 10.1155/2016/6123951. Epub 2016 Jan 20.
增殖细胞核抗原在儿童肾母细胞瘤中的预后价值
Eur J Surg Oncol. 2002 Feb;28(1):67-71. doi: 10.1053/ejso.2001.1208.
4
Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor.免疫组织化学检测p53蛋白表达作为肾母细胞瘤的预后指标
Med Pediatr Oncol. 2001 Nov;37(5):455-8. doi: 10.1002/mpo.1229.
5
p53 expression in Wilms' tumor: a possible role as prognostic factor.p53在肾母细胞瘤中的表达:作为预后因素的可能作用。
Int J Oncol. 2001 Jan;18(1):133-9.
6
Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study.印度儿童肾母细胞瘤的前驱病变:一项多机构研究。
Cancer. 1998 Nov 15;83(10):2228-32.
7
Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour.通过MIB-1抗体测定的肾母细胞瘤中的肿瘤细胞增殖率。
Pol J Pathol. 1997;48(2):113-9.
8
Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group.肾母细胞瘤中的局灶性与弥漫性间变——具有预后意义的新定义:来自国家肾母细胞瘤研究组的报告
Am J Surg Pathol. 1996 Aug;20(8):909-20. doi: 10.1097/00000478-199608000-00001.
9
Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.肾母细胞瘤中p53的免疫组化检测与不良预后相关。
Am J Pathol. 1996 May;148(5):1577-89.
10
Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.p53肿瘤抑制基因的突变在肾母细胞瘤中很少发生。
Cancer Res. 1994 Apr 15;54(8):2077-9.